Healthcare company Labcorp announced Tuesday, Jan. 20 a multi-year plan for a new, purpose-built, high-tech facility for its ...

Labcorp added to its suite of tests designed to detect cancer recurrence much earlier than traditional imaging.

Pixel by LabCorp ℠ Offers Self-Collected Testing Anytime, Anywhere to Empower Healthcare Consumers BURLINGTON, N.C.--(BUSINESS WIRE)--LabCorp® (NYSE: LH), a leading global life sciences company, today ...

BURLINGTON, N.C.--(BUSINESS WIRE)--Labcorp® (NYSE: LH), a leading global life sciences company, today announced a new collaboration with HealthVerity, Inc., the ...

BURLINGTON, N.C.--(BUSINESS WIRE)--Labcorp (NYSE: LH), a leading global life sciences company, today announced that the new company to be formed by the planned spin-off of its Clinical Development ...

Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that its Board of Directors has declared a cash dividend of $0.72 per share of ...

“Adding Toxikon underscores our commitment to nonclinical development and advances our capabilities for both drug development and medical device testing,” said Dr. Paul Kirchgraber, CEO of Labcorp ...

Quest and Labcorp may be archrivals in the diagnostic testing market, but they appear to agree on at least one thing: the ...

The global life sciences and health care company did not explain why it is closing the facility. The post Labcorp is closing ...

Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, will release its financial results for the fourth quarter of 2025 before the market opens on ...

Lumipulse® pTau-217/Beta Amyloid 42 Ratio now available nationwide through Labcorp BURLINGTON, N.C., Aug. 18, 2025 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive ...

Strategic Partnership Includes Development of New Facility, Enhanced Service for Global Clinical Trials Through the planned laboratory expansion, Labcorp will advance biomarker and esoteric testing ...